Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients
Holly L. Geyer(Mayo Clinic Hospital), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Pablo Muxí(Hospital Británico), Zhijian Xiao(Institute of Hematology & Blood Diseases Hospital), Gunnar Birgegård(Uppsala University Hospital), Robyn M. Scherber(Blueprint Medicines (United States)), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Carlos Besses(Hospital Del Mar), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Deepti Radia(St Thomas' Hospital), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Jan Samuelsson(Karolinska University Hospital), Peter Johansson(Linköping University), Konstanze Döhner(University Hospital Ulm), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Federico Sackmann(Centre Hospitalier Universitaire de Grenoble), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tiziano Barbui(University of Bergamo), Sonja Zweegman(Vrije Universiteit Amsterdam), Amylou C. Dueck(Mayo Clinic in Arizona), Jean‐Jacques Kiladjian(Délégation Paris 5), Ana Kerguelen Fuentes(Centre Hospitalier Universitaire de Grenoble), Francesco Passamonti(University of Milan)
Cited by 93
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k